We recently hosted a Misti lunch, bringing together our dedicated team members and major supporters to celebrate Misti's 2nd birthday. 🎉 We even had a special cake to mark this occasion! 🍰 Reflecting on the past two years, we're amazed at how far we've come. None of this would have been possible without your incredible support. We share our journey and celebrate every ‘mile-pebble’ 🪨 (instead of 'milestone) in our quarterly newsletter. Subscribe today to stay updated: https://lnkd.in/gUmMVt_U
Misti
Biotechnology
Melbourne, Victoria 737 followers
Next-generation lung delivery to protect every vulnerable child and adult from infections
About us
Respiratory diseases such as influenza, COVID-19, and human respiratory syncytial virus (RSV) remain significant health issues. MISTI is an Australian SME developing a first-in-class advanced medication delivery platform for the delivery of therapeutic biomolecules to the lungs, specifically to address this problem. The technology can be used to deliver mRNA, antibodies as well as small molecules and antigens (proteins).
- Website
-
https://www.misti.com.au/
External link for Misti
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- Melbourne, Victoria
- Type
- Privately Held
Locations
-
Primary
Melbourne, Victoria, AU
Employees at Misti
-
Dr. Anushi (Kulasiri) Rajapaksa
🫁 Scientist turned Impact driven Founder @Misti_au | Senior Scientist 15 years | NHMRC Research Fellow | Speaker | Empowering Women in STEMM ✨️…
-
Hamish McWilliam
Senior Research Fellow @ The Doherty Institute, The University of Melbourne Lead Immunologist @ Misti
-
Mamatha Hanuma Raju
PhD student at RMIT University | Misti | Material Chemistry | Crystal growth | Polymer chemistry | Optoelectronic devices | In2Science mentor
-
Bangyan Xu
Postdoctoral research fellow
Updates
-
Welcome aboard, Mamatha Hanuma Raju! 🎉 We’re thrilled to officially welcome Mamatha to the Misti team. As a final-year PhD candidate at RMIT University, Mamatha brings a wealth of expertise in material chemistry, microscopy, polymer chemistry, and optical devices. With a background in Electronics Engineering and a research focus on photo-active materials for solar cells, her diverse knowledge is undoubtedly invaluable. Outside academia, Mamatha mentors high school students with In2science, inspiring the next generation of scientists. During her internship at Misti, she’ll leverage her extensive experience in nano/micro fabrication and circuit development to drive innovation in our premier cleanroom at Melbourne Centre for Nanofabrication. Mamatha is joining Misti through an inspiring research-industry internship collaboration brought together by APR.Intern. The internship is jointly funded by the Australian Government Women in STEM & Entrepreneurship (WiSE) grants program, The Defence Science Institute, and Misti. She will be supervised by Dr. Anushi (Kulasiri) Rajapaksa. Join us in welcoming Mamatha to our team and celebrating the positive impact she’s sure to make. We’re excited to have her on this journey with us! #MistiTeam #welcome
-
We’re thrilled to announce that Misti is one of the 23 ventures shortlisted for Cicada x Tech23 2024! 🎉 It’s an honour to stand alongside such incredible innovators and we can't wait to showcase our work in Sydney on August 7th. Congratulations to the 23 Adept Aqua Agscent Alt.Leather Aquila Convergence Medical Crest Robotics Deneb Space DermR Health Dilji Labs Eco Shield Systems Pty Ltd EM ENERGY Nourish Ingredients newera.bio OCIUS Technology Limited OminiWell Pty Ltd PlasmaLeap Technologies Roam Technologies (roamtech.ai) Stralis Aircraft (YC W23) Telemattica Tetratherix VetChip Zondii If you’d like to support us and the other teams, or if you’re a deep tech enthusiast, secure your spot here: https://lnkd.in/gjD2D44X #CxT23 #innovation #tech #deeptech #techfestival #australianstartups #innovationtech
📣 Attention deep tech innovators, investors and enthusiasts! 📣 Big news alert — We're thrilled to introduce you to the 23 extraordinary ventures taking the stage at Cicada x Tech23, Australia's largest deep tech festival, on the 7th of August. 🎊. Secure your tickets below. 👇 From microclimates on skyscrapers to water-emitting aircraft, these startups are transforming industries, working on the most radical innovations to tackle some of the world's most pressing problems. Cicada x Tech 23 will again spotlight the best of Australian deep ventures pushing the boundaries of science, innovation, and technology and celebrate the people with bold and big ambitions behind them. This is not your traditional startup pitchfest. The 23 startups are organised into “systems”, themed streams featuring ‘Resilient Farm & Food Systems, A waste free world, Shifting the mindset on medicine and Built Environment Reimagined’, that anticipate the future opportunities and challenges for Australia and the world. We can't wait to spotlight their vision and big ideas to you and all of Australia! Meet the 23: Adept Aqua Agscent Alt.Leather Aquila Convergence Medical Crest Robotics Deneb Space DermR Health Dilji Labs Eco Shield Systems Pty Ltd EM ENERGY Misti Nourish Ingredients newera.bio OCIUS Technology Limited OminiWell Pty Ltd PlasmaLeap Technologies Roam Technologies (roamtech.ai) Stralis Aircraft (YC W23) Telemattica Tetratherix VetChip Zondii Head to our blog to learn more about them: https://lnkd.in/gxJGPcnV If you're a leader in the ecosystem with a passion for supporting deep tech startups, then secure your ticket here: https://lnkd.in/gjD2D44X Cicada x Tech23 is proudly sponsored by Main Sequence Ventures, Investment NSW, Australian Government Department of Industry, Science and Resources, CSIRO, University of Sydney, University of Technology Sydney, South Eveleigh, KPMG High Growth Ventures, Addisons, CFO Plus - Your Outsourced Finance Department, Monash University, Radium Capital , Techvisa, and City of Sydney. #CxT23 #innovation #tech #deeptech #techfestival #australianstartups #innovationtech
-
We're thrilled to secure a $50,000 MedTech Market Growth Program Grant from LaunchVic, Australian Medtech Manufacturing Centre (AMMC) and Department of Jobs, Skills, Industry and Regions. This grant is super time-critical for us as we develop Victorian manufacturing capabilities right here in Melbourne. It will enable us to access essential skills, services and resources to advance our life-saving products and accelerate our product development. Misti's mission? To build Australia's first nebuliser mask and create a revolutionary medication delivery platform targeting respiratory tract infections. These infections severely impact vulnerable populations, especially children and the elderly, in both developed and developing countries. Our goal: Rapid Respiratory Relief anywhere, anytime! This program supports scaling medtech companies in driving innovation, attracting investment, fast-tracking market growth and creating new local jobs. For more information, visit: https://lnkd.in/gYae2gUY
-
🎉 Misti is celebrating our 2nd birthday today! 🎉 We’re excited to unveil our newly revamped website, designed with you in mind. Explore our updated look, learn more about our innovative technology and offerings, and get in touch with us at https://www.misti.com.au/ What do you think of the new look? Let us know in the comments 👇 #MistiAnniversary #WebsiteLaunch #Innovation #HealthcareTech
-
Curious about Misti's mission and the market need we're addressing? Explore the current challenges in respiratory relief for children and why comprehensive solutions are essential in this post 💡 At Misti, we're dedicated to alleviating respiratory discomfort for families, one breath at a time. 🌬️💙
-
1
-
We are immensely proud of Bangyan Xu's incredible growth during his APR.Intern internship at MISTI. This must-read article showcases his pivotal work in applying immunology and cellular biology to develop an innovative vaccine delivery method using surface acoustic wave (SAW) nebulization technology. Discover more about Bangyan's inspiring journey and the groundbreaking work happening at MISTI in this article https://lnkd.in/ggMxkDtc #Innovation #Immunology #CellularBiology #VaccineDelivery #MISTI
IMPACT: Through his APR PhD internship at Misti, Bangyan Xu participated in groundbreaking research that has the potential to provide equitable access to vaccines, alleviate disease burden in vulnerable populations, and contribute to sustainable healthcare solutions. Misti stands strong in their commitment to fostering next-generation talent, it’s crucial to equip young scientists with commercial innovation skills. Read more: https://lnkd.in/ggMxkDtc
-
Following Sanjana's inspiring story, meet Bangyan Xu, Misti's R&D Immunologist and former APR.Intern intern! 🌟 Watch Bangyan share the biggest highlights from his internship at Misti. From impactful projects to opportunities for multidisciplinary collaboration, his incredible experiences last beyond the internship as he continues his work with us. 🔔 The next round of APR.Intern application is open and closing in just 1 day - Don't miss out! Spread the word to your network today. If you're a postgraduate research student, don't miss this chance to join a rapidly growing startup and work on pioneering solutions in aerosolised therapy. 👉 Apply today https://lnkd.in/gF4n2HGe #APRIntern #Internship #HealthTech #CareerGrowth #Misti #Engineering #Immunology #ApplyNow #Innovation
-
Meet Sanjana Prasad, the brilliant mind behind some of Misti's most innovative projects! Starting as an APR.Intern postgraduate intern, Sanjana's passion and dedication led her to be an essential part of our team today as an R&D Engineer. Watch Sanjana share the highlights of her internship. Want to explore first-hand the work of a young and fast-growing health tech startup? Our next round of APR.Intern project is open – apply here https://lnkd.in/gF4n2HGe
-
It's one good news after the others! ⭐️ We are thrilled to be among the seven research-driven ventures selected to join the 2024 TRAM Air prestigious program. Over the next six months, Misti will receive invaluable mentorship from Emerson Keenan and Jon Dusting, seasoned business executives and later-stage founders. This support will empower us as we strive towards scale and further our commercialisation success. We're ready to embark on this journey with confidence and thrive alongside our exceptional cohort peers!
Meet the 2024 TRAM Air Cohort! Six research-driven ventures from the University of Melbourne and the Melbourne Biomedical Precinct have been selected to partake in our TRAM Air program. A very warm welcome to the following teams: ⭐️ VisCAT - Christine Nearchou Faculty of Medicine, Dentistry and Health Sciences ⭐️ FeBi Technologies - Nicole Jenkins, Gawain Mccoll, David Simpson and Liam Hall The Florey Institute of Neuroscience and Mental Health (The Florey) and University of Melbourne Faculty of Science ⭐️ VoltMind - Michael Liu, Vincenzo Bassi Zillmann and Nando Ochoa Faculty of Engineering and Information Technology ⭐️ Misti - Dr. Anushi (Kulasiri) Rajapaksa Peter Doherty Institute for Infection and Immunity ⭐️ Meizon Innovation - Liz Ferentinos, Albert Frauman and Wah Chin Boon The Florey Institute of Neuroscience and Mental Health (The Florey) ⭐️ Mirugen - Raymond Wong Centre for Eye Research Australia (CERA) Led by Masha, our TRAM Air Program Manager, these teams are ready to tackle some of the world’s most pressing issues over the next six months. We were also joined by Andrew J. Nash, TRAM's lead mentor, in Melbourne for the program kick off! Click the link below to learn more about our 2024 Air teams ⬇ https://lnkd.in/gzRvxcvh -- #TRAMAir #ResearchCommercialisation 🔗Colin McLeod, Andrew Rowse, Matt Broughton